Concepedia
Statistics
Publications
11
Citations
621
H-Index
Active since
1988
Affiliations
Pfizer (United States)(Current)
Pfizer (Italy)
Universidade de Santiago de Compostela
Pfizer (Spain)
M.J. Lechuga is an author at Pfizer (United States) specializing in pharmacology, medicine, and cancer pharmacology.
Publications per year
1988–2015
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
Martin Gore, Cezary Szczylik, Camillo Porta et al. · British Journal of Cancer · 2015 · 191 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials
Ana M. Molina, Xun Lin, Beata Korytowsky et al. · European Journal of Cancer · 2013 · 157 citations
Medicine, Oncology, Pharmacology +13
REASONS FOR THE VARIABILITY IN GROWTH HORMONE (GH) RESPONSES TO GHRH CHALLENGE: THE ENDOGENOUS HYPOTHALAMIC‐SOMATOTROPH RHYTHM (HSR)
Jesús Devesa, Luis Lima, Noemi Lois et al. · Clinical Endocrinology · 1989 · 78 citations
Medicine, Endocrinology, Physiology +17
Assessment of safety and drug-induced tumor necrosis with sunitinib in patients (pts) with unresectable hepatocellular carcinoma (HCC)
Sandrine Faivre, Éric Raymond, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 2007 · 72 citations
Medicine, Oncology, Pharmacology +17
Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
Kewn‐wook Lee, S. R. Park, Do‐Youn Oh et al. · Investigational New Drugs · 2013 · 28 citations
Medicine, Oncology, Pharmacology +12
1–5 of 11